# Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China

> **NCT01933646** · — · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 10 (actual)

## Conditions studied

- Invasive Group B Streptococcal Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01933646
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01933646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01933646, "Burden of Invasive Group B Streptococcal (GBS) Disease in Young Infants in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01933646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*